Membranous Lupus Nephritis: A Clinical Review

被引:23
|
作者
Almaani, Salem [1 ]
Parikh, Samir V. [1 ]
机构
[1] Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Div Nephrol, 395 W 12th Ave, Columbus, OH 43210 USA
关键词
Systemic lupus erythematosus; Lupus nephritis; Membranous lupus nephritis; Class V lupus nephritis; BLOOD-PRESSURE CONTROL; NEPHROTIC SYNDROME; CONTROLLED-TRIAL; DOUBLE-BLIND; ERYTHEMATOSUS PATIENTS; MYCOPHENOLATE-MOFETIL; KIDNEY-DISEASE; REPEAT BIOPSY; TERM; ALDOSTERONE;
D O I
10.1053/j.ackd.2019.08.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Membranous lupus nephritis (MLN) (Class V lupus nephritis [LN]) is a distinct form of LN defined by the presence of subepithelial immune complex deposits seen on kidney biopsy. MLN is often associated with the nephrotic syndrome. The histology of MLN closely resembles that of idiopathic (primary) membranous nephropathy (pMN). However, MLN typically has abundant mesangial deposits that are absent in primary membranous nephropathy. The clinical presentation, management, and prognosis of MLN differ from that of the proliferative forms of LN (Class III, IV, or Mixed III/IV + V). Although immunosuppressive therapy is often warranted in MLN, the optimal treatment regimen remains unclear. Here we describe the clinical presentation, histologic features, and natural history of MLN. We also review the role of supportive treatment and discuss when to deploy immunosuppressive management in MLN. (C) 2019 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:393 / 403
页数:11
相关论文
共 50 条
  • [1] Treatment of Proliferative and Membranous Lupus Nephritis: Review of Key Clinical Trials
    Alshayeb, Hala
    Wall, Barry M.
    Gosmanova, Elvira O.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 343 (01): : 86 - 90
  • [2] THE CLINICAL AND PATHOLOGICAL ASPECTS OF MEMBRANOUS LUPUS NEPHRITIS
    YAO, XD
    LI, LS
    CHEN, HP
    WANG, QW
    KIDNEY INTERNATIONAL, 1995, 48 (02) : 621 - 621
  • [3] MEMBRANOUS LUPUS NEPHRITIS: CLINICAL PRESENTATION AND OUTCOME
    Alba, P.
    Plaisance, M.
    Cuadrado, M. J.
    Karim, M. Y.
    Tungekar, M. F.
    Abbs, I. C.
    D'Cruz, D. P.
    Khamashta, M. A.
    Hughes, G. R. V.
    RHEUMATOLOGY, 2002, 41 : 106 - 106
  • [4] CLINICAL MANIFESTATION OF MEMBRANOUS LUPUS NEPHRITIS IN CHILDREN
    Opastirakul, Sauwalak
    Chartapisak, Wattana
    PEDIATRIC NEPHROLOGY, 2009, 24 (03) : 664 - 665
  • [5] Membranous lupus nephritis
    Austin, HA
    Illei, GG
    LUPUS, 2005, 14 (01) : 65 - 71
  • [6] CLINICAL COURSE OF PROLIFERATIVE AND MEMBRANOUS FORMS OF LUPUS NEPHRITIS
    BALDWIN, DS
    LOWENSTEIN, J
    ROTHFIELD, NF
    GALLO, G
    MCCLUSKEY, RT
    ANNALS OF INTERNAL MEDICINE, 1970, 73 (06) : 929 - +
  • [7] Clinical characterisitcs and treatment outcome of membranous lupus nephritis
    Lim, S. K.
    Thye, Y. L.
    Keng, T. C.
    Cheah, P. L.
    Looi, L. M.
    Tan, S. Y.
    NEPHROLOGY, 2008, 13 : A47 - A48
  • [8] MEMBRANOUS TRANSFORMATION OF LUPUS NEPHRITIS
    LENTZ, RD
    MICHAEL, AF
    FRIEND, PS
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1981, 19 (01): : 131 - 138
  • [9] Treatment of membranous lupus nephritis
    Moroni, G
    Maccario, M
    Banfi, G
    Quaglini, S
    Ponticelli, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) : 681 - 686
  • [10] SYSTEMATIC REVIEW AND META-ANALYSIS OF IMMUNOSUPPRESSANT THERAPY CLINICAL TRIALS IN MEMBRANOUS LUPUS NEPHRITIS
    Swan, J.
    Majithia, V.
    Riche, D.
    Riche, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 369 - 369